Consideration of aggressive therapeutic strategies for primary testicular lymphoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Byeong-Bae | - |
dc.contributor.author | Kim, Jong Gwang | - |
dc.contributor.author | Sohn, Sang Kyun | - |
dc.contributor.author | Kang, Hye Jin | - |
dc.contributor.author | Lee, Seung Sook | - |
dc.contributor.author | Eorn, Hyeon Seok | - |
dc.contributor.author | Kwon, Hyuck Chan | - |
dc.contributor.author | Oh, Sung Yong | - |
dc.contributor.author | Kang, Jung Hun | - |
dc.contributor.author | Oh, Suk Jooni | - |
dc.contributor.author | Shin, Ho-Jin | - |
dc.contributor.author | Suh, Cheolwon | - |
dc.contributor.author | Kim, Jung Han | - |
dc.contributor.author | Kim, Ho Younj | - |
dc.contributor.author | Kim, Kihyun | - |
dc.contributor.author | Ryoo, Baek Yeol | - |
dc.contributor.author | Kim, Won Seog | - |
dc.date.accessioned | 2022-10-07T10:56:52Z | - |
dc.date.available | 2022-10-07T10:56:52Z | - |
dc.date.created | 2022-08-26 | - |
dc.date.issued | 2007-09 | - |
dc.identifier.issn | 0361-8609 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/172244 | - |
dc.description.abstract | To evaluate the clinical features and treatment of primary testicular lymphoma, 45 cases were retrospectively evaluated. The median age of the patients was 59 years (range, 40-81) and most patients (76%) presented with Stages I-II. All patients underwent an orchiectomy, after which various treatments were given, chemotherapy alone in 37 patients (60%) and chemotherapy with involved field radiotherapy (IFRT) in 15 patients (33%). Prophylactic intrathecal chemotherapy was given to six patients; cranial irradiation was given in two patients. Eleven patients (24%) received prophylactic irradiation or surgery on the contralateral testis. In 40 patients able to be evaluated, complete response (CR) rate was 78%; 11 of 31 CR patients (36%) had relapsed. Relapse or disease progression was observed in 21 patients. The most frequent site (44%) was in the CNS. The median progression free survival and overall survival were 16 and 34 months, respectively. Ten patients who received prophylactic radiation to the contralateral testis had no relapse in this site. In six patients who received prophylactic intrathecal chemotherapy, there was no leptomeningeal progression, but brain parenchymal relapse occurred in two patients. In multivariate analysis, Stage I (P = 0.02) and additional IFRT after orchiectomy (P = 0.01) were found to be good prognostic factors. In conclusion, orchiectomy followed by intensive chemotherapy and IFRT including prophylaxis to the CNS and contralateral testis, should be considered as initial treatment in primary testicular lymphoma. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | WILEY-LISS | - |
dc.title | Consideration of aggressive therapeutic strategies for primary testicular lymphoma | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Byeong-Bae | - |
dc.identifier.doi | 10.1002/ajh.20973 | - |
dc.identifier.scopusid | 2-s2.0-35748958452 | - |
dc.identifier.wosid | 000249293300017 | - |
dc.identifier.bibliographicCitation | AMERICAN JOURNAL OF HEMATOLOGY, v.82, no.9, pp.840 - 845 | - |
dc.relation.isPartOf | AMERICAN JOURNAL OF HEMATOLOGY | - |
dc.citation.title | AMERICAN JOURNAL OF HEMATOLOGY | - |
dc.citation.volume | 82 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 840 | - |
dc.citation.endPage | 845 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Hematology | - |
dc.relation.journalWebOfScienceCategory | Hematology | - |
dc.subject.keywordPlus | NON-HODGKINS-LYMPHOMA | - |
dc.subject.keywordPlus | PROPHYLACTIC CRANIAL IRRADIATION | - |
dc.subject.keywordPlus | DOXORUBICIN-BASED THERAPY | - |
dc.subject.keywordPlus | LARGE-CELL LYMPHOMA | - |
dc.subject.keywordPlus | MALIGNANT-LYMPHOMA | - |
dc.subject.keywordPlus | EXTRANODAL RECURRENCE | - |
dc.subject.keywordPlus | LUNG-CANCER | - |
dc.subject.keywordPlus | TESTIS | - |
dc.subject.keywordPlus | CHEMOTHERAPY | - |
dc.subject.keywordPlus | PATTERNS | - |
dc.identifier.url | https://onlinelibrary.wiley.com/doi/10.1002/ajh.20973 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.